More FDA-approved generic and biosimilar medicines are available now than ever before. Today, America’s patients are benefitting from significant savings at the pharmacy counter and in lower out-of-pocket costs. But those savings are increasingly at risk due to anti-competitive abuses and misguided policies that block access to lower-cost medicines.
Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.
#Rx4Savings
Issues